Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
15.44 +0.21 (+1.38%) 11:22 ET [NASDAQ]
15.47 x 100 15.50 x 200
Realtime by (Cboe BZX)
15.47 x 100 15.50 x 200
Realtime 15.20 -0.03 (-0.16%) 09:28 ET
Quote Overview for Wed, Mar 5th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
15.15
Day High
15.58
Open 15.28
Previous Close 15.23 15.23
Volume 193,619 193,619
Avg Vol 977,280 977,280
Stochastic %K 27.27% 27.27%
Weighted Alpha -38.21 -38.21
5-Day Change +0.02 (+0.13%) +0.02 (+0.13%)
52-Week Range 11.40 - 27.20 11.40 - 27.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,206,018
  • Shares Outstanding, K 79,213
  • Annual Sales, $ 300 K
  • Annual Income, $ -269,950 K
  • EBIT $ -212 M
  • EBITDA $ -265 M
  • 60-Month Beta 1.05
  • Price/Sales 3,779.67
  • Price/Cash Flow N/A
  • Price/Book 1.78

Options Overview Details

View History
  • Implied Volatility 80.52% ( -5.02%)
  • Historical Volatility 45.91%
  • IV Percentile 53%
  • IV Rank 31.78%
  • IV High 193.07% on 08/13/24
  • IV Low 28.08% on 05/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 63
  • Volume Avg (30-Day) 120
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 2,906
  • Open Int (30-Day) 3,440

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.97
  • Number of Estimates 8
  • High Estimate -0.77
  • Low Estimate -1.09
  • Prior Year -0.79
  • Growth Rate Est. (year over year) -22.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.05 +10.68%
on 03/04/25
Period Open: 19.24
19.44 -20.01%
on 02/06/25
-3.69 (-19.18%)
since 02/05/25
3-Month
14.05 +10.68%
on 03/04/25
Period Open: 19.63
23.65 -34.25%
on 12/16/24
-4.08 (-20.78%)
since 12/05/24
52-Week
11.40 +36.40%
on 06/04/24
Period Open: 18.11
27.20 -42.83%
on 11/12/24
-2.56 (-14.14%)
since 03/05/24

Most Recent Stories

More News
Viridian Therapeutics Stock Hits 3-Week High, Retail Buzz Builds On Chronic Thyroid Eye Disease Trial Data

The company confirmed that it remains on track to submit a marketing application for veligrotug to U.S. regulators in the second half of 2025.

VRDN : 15.44 (+1.38%)
Stocks Recover Early Losses and Close Higher as Chip Stocks Surge

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up by +1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +2.17%. Stocks...

$SPX : 5,763.06 (-0.26%)
SPY : 574.37 (-0.43%)
$DOWI : 42,504.53 (-0.04%)
DIA : 424.95 (-0.15%)
$IUXX : 20,278.56 (-0.36%)
QQQ : 492.77 (-0.56%)
ZNM25 : 111-030 (-0.14%)
ARM : 120.72 (-1.45%)
NVDA : 115.04 (-0.82%)
AVGO : 188.44 (+0.51%)
ASML : 726.20 (+2.54%)
KLAC : 694.25 (-0.68%)
Stocks Move Higher After Today's CPI Report

The S&P 500 Index ($SPX ) (SPY ) today is up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.52%. After starting the day in...

$SPX : 5,763.06 (-0.26%)
SPY : 574.37 (-0.43%)
$DOWI : 42,504.53 (-0.04%)
DIA : 424.95 (-0.15%)
$IUXX : 20,278.56 (-0.36%)
QQQ : 492.77 (-0.56%)
ZNM25 : 111-030 (-0.14%)
DFS : 176.92 (-1.07%)
COF : 182.40 (-1.35%)
RF : 21.68 (-3.04%)
CFG : 42.95 (-1.47%)
CINF : 142.67 (-0.41%)
Stocks Undercut as US Core Inflation Fails to Decline

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.19%. Stocks are under...

$SPX : 5,763.06 (-0.26%)
SPY : 574.37 (-0.43%)
$DOWI : 42,504.53 (-0.04%)
DIA : 424.95 (-0.15%)
$IUXX : 20,278.56 (-0.36%)
QQQ : 492.77 (-0.56%)
ZNM25 : 111-030 (-0.14%)
NVDA : 115.04 (-0.82%)
ASML : 726.20 (+2.54%)
ARM : 120.72 (-1.45%)
MRVL : 86.99 (-1.52%)
MU : 91.45 (+0.27%)
3 Top Small-Cap Tech Picks for Investors This Month

Wall Street believes these three small companies have significant upside potential.

AMZN : 204.92 (+0.55%)
MSFT : 391.49 (+0.74%)
NVDA : 115.04 (-0.82%)
CHPT : 0.7099 (+7.53%)
$SPX : 5,763.06 (-0.26%)
VRDN : 15.44 (+1.38%)
SLNO : 44.02 (-0.95%)
2 Growth Stocks Wall Street Analysts Think Can Double in Value

Is now a good time to buy these promising healthcare stocks?

VRDN : 15.44 (+1.38%)
DNA : 8.04 (-0.99%)
Why Shares of Viridian Therapeutics Are Falling Tuesday

The company announced preliminary trial results for its lead therapy.

HZNP : 116.30 (+0.04%)
VRDN : 15.44 (+1.38%)
Why These 2 Nasdaq Biotech Stocks Fell Hard Tuesday Morning

Broader markets seemed likely to start out on a positive note despite these two outliers.

COMP : 9.05 (-0.44%)
$NASX : 18,236.16 (-0.27%)
VRDN : 15.44 (+1.38%)
IOVA : 3.91 (-0.26%)
Viridian Therapeutics (NASDAQ: VRDN) Shares Positive Clinical Data from Phase 1/2 Trial of VRDN-001 for Treatment of Thyroid Eye Disease

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is engaged as a biotechnology company, which is focused on the research and development of

VRDN : 15.44 (+1.38%)
Bed Bath & Beyond Leads Meme Stocks, But Here's Monday's Big Stock Winner

In a dour market open, here's why these stocks are on the rise.

COMP : 9.05 (-0.44%)
$DOWI : 42,504.53 (-0.04%)
$SPX : 5,763.06 (-0.26%)
$NASX : 18,236.16 (-0.27%)
BBBY : 0.0751 (-27.09%)
VRDN : 15.44 (+1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

See More

Key Turning Points

3rd Resistance Point 16.88
2nd Resistance Point 16.08
1st Resistance Point 15.65
Last Price 15.44
1st Support Level 14.42
2nd Support Level 13.62
3rd Support Level 13.19

See More

52-Week High 27.20
Fibonacci 61.8% 21.16
Fibonacci 50% 19.30
Fibonacci 38.2% 17.44
Last Price 15.44
52-Week Low 11.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Mastering Fibonacci: The Hidden Order in Market Movements